ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study to Assess Whether Proinsulin Peptide Injections Can Slow or Stop the Body Damaging Its Own Insulin-making Cells in the Pancreas in Patients Newly Diagnosed With Type 1 Diabetes (MonoPepT1De)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01536431
Recruitment Status : Completed
First Posted : February 22, 2012
Last Update Posted : July 28, 2015
Sponsor:
Collaborators:
Diabetes Vaccine Development Centre
Juvenile Diabetes Research Foundation
Information provided by (Responsible Party):
Professor Colin Dayan, Cardiff University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2015
  Actual Study Completion Date : February 2015